Alexandra E. Rojek, MD¹, Nausheen Ahmed, MD², Marina Gomez Llobell, MD, MS^3*, Sairah Ahmed, MD⁴, Marie Hu, MD⁵, Monica Mead, MD⁶, Andy Chen, MD, PhD⁷, Vivek Patel, MD⁸, Jamie Brower, MS^9*, Veronika Bachanova, MD, PhD⁵, Richard T. Maziarz, MD⁷, Olalekan O. Oluwole, MD, MPH, MBBS⁸, Michael R Bishop, MD^1,10, David L. Porter, MD⁹, Miguel Angel Perales, MD³, Joseph P. McGuirk, DO¹¹, Peter A. Riedell, MD^1,10 and Daniel J. Landsburg, MD⁹

¹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
²University of Kansas Cancer Center, Kansas City, KS
³Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
⁶Department of Medicine/Division of Hematology and Oncology, UCLA Medical Center, Los Angeles, CA
⁷Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁸Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
⁹Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
¹⁰David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
¹¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS

Ofrat Beyar-Katz, MD, PhD^1,2*, Ohad Benjamini, MD^3*, Julio Delgado, MD, PhD^4*, Marco Ruella, MD⁵, Ron Ram^6*, Sigal Grisariu, MD^7,8*, Andrea Visentin, MD, PhD^9*, Elisabeth Vandenberghe, MD, PhD^10,11*, Massimo Gentile, MD^12,13*, Abraham Avigdor, MD^14,15, Avichai Shimoni, MD^14*, Roni Shouval, MD, PhD^16,17, Ronit Marcus, MD^18,19*, Stephen J. Schuster, MD^5,20, Valentin Ortiz-Maldonado, MD, PhD, MSc²¹, Guido Ghilardi, MD^22*, Luca Paruzzo, MD^22*, Tsila Zuckerman, MD^1,23, Tamar Tadmor, MD^24*, Riva Fineman, MD^25*, Odelia Amit, MD^26*, Nuria Martinez-Cibrian^27*, Giulia Gabrielli, MD^28*, Batia Avni, MD^7,8*, Eva Minga^29*, Noga Shem-Tov, MD^14,18*, Lydia Scarfo, MD³⁰, Ronit Yerushalmi, MD^3,15*, Arnon Nagler, MD^14,31, Ronit Leiba^32*, Ivetta Danylesko, MD^3,15*, Kostas Stamatopoulos^29*, Thomas Chatzikonstantinou, MD^29*, Paolo Ghia, MD, PhD³³ and Yair Herishanu, MD^34,35*

¹Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
²Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus; The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel
³Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Oncoimmunotherapy Unit, Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain
⁵Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁶Bone Marrow Transplant Unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁷Faculty of Medicine, The Hebrew University, Jerusalem, Israel
⁸Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Jerusalem, Israel
⁹Hematology unit, Department of Medicine, University of Padova, Padova, Italy
¹⁰Department of Haematology, St. James's Hospital, Dublin, Ireland
¹¹Trinity College Dublin, Dublin, Ireland
¹²Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy
¹³Hematology Unit, Azienda Ospedaliera di Cosenza, Cosenza, Italy
¹⁴Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
¹⁵Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
¹⁶Department of Medicine, Weill Cornell Medicine, New York, NY
¹⁷Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁸Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat Gan, Israel
¹⁹School of Medicine, Faculty of Medical and health Sciences,Aviv University, Tel Aviv, Israel
²⁰Center for Cellular Therapy, University of Pennsylvania, Philadelphia, PA
²¹Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Seattle, WA
²²Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²³Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Moshav Ein Ayalla, Israel
²⁴Hematology Unit, Bnai Zion Medical Center, Haifa, Israel
²⁵Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
²⁶BMT Unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²⁷Hospital Clínic de Barcelona, Barcelona, Spain
²⁸Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
²⁹Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
³⁰Division of Experimental Oncology, IRCCS Ospedale San Raffaele Milan Italy., Milano, Italy
³¹Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel
³²Department of Statistics, Rambam Health Care Campus, Haifa, Israel
³³Università Vita-Salute San Raffaele, Milano, Italy
³⁴Bone Marrow Transplantation Unit, Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel
³⁵Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel

Emilie Charton^1*, Amelie Anota^1*, Emmanuel Bachy, MD, PhD², Guillaume Cartron, MD, PhD^3*, François-Xavier Gros, MD^4*, Franck Morschhauser, MD, PhD⁵, Lucie Oberic, MD^6*, Thomas Gastinne, MD^7*, Pierre Feugier, MD, PhD^8*, Remy Dulery, MD, PhD^9*, Catherine Thieblemont, MD¹⁰, Magalie Joris, MD^11*, Fabrice Jardin, MD, PhD^12*, Sylvain Choquet, MD^13*, Olivier Casasnovas, MD^14*, Gabriel Brisou, MD, PhD^15*, Morgane Cheminant, MD, PhD^16*, Jacques-Olivier Bay, MD, PhD^17*, Francesco Llamas Gutierrez, MD^18*, Cédric Portugues^19*, Emmanuel Itti, MD, PhD^20*, Xavier Pallard, MD, PhD^21*, Paul Blanc-Durand^22*, Yassine Al Tabaa, MD, PhD, PharmD^23*, Clément Bailly, MD, PhD^24*, Camille Laurent, MD, PhD^25*, Francois Lemonnier^26* and Roch Houot, MD, PhD^27*

¹Centre Léon Bérard, Lyon, FRA
²Lyon Sud Hospital, Lyon, France
³Centre Hospitalier Universitaire de Montpellier, Montpellier, France
⁴Hematology Department, Bordeaux University Hospital, Pessac, France
⁵Centre Hospitalier Régional Universitaire de Lille, Lille, France
⁶IUCT - Oncopole, Hematology Department, Toulouse, France
⁷Centre Hospitalier Universitaire de Nantes, Nantes, France
⁸CHU Brabois - Service d'Hématologie - Université Henri Poincaré, Nancy, France
⁹Clinical Hematology and Cellular Therapy, Sorbonne University, Saint-Antoine Hospital, Assistance Publique - Hôpitaux de Paris, INSERM UMRs 938, Paris, Île-de-France, France
¹⁰Hospital Saint-Louis, Paris, France
¹¹Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
¹²INSERM U1245, Cancer and Brain Genomics, Centre Henri Becquerel, University of Rouen, Rouen, France
¹³Pitie-Salpetriere Hospital, Paris, France
¹⁴François Mitterand Hospital, Dijon, FRA
¹⁵Institut Paoli-Calmettes, Marseille, France
¹⁶Hopital Necker - Enfants Malades, AP-HP, Department of Hematology, Paris, France
¹⁷CHU ESTAING, Clermont-Ferrand, France
¹⁸Department of Pathology, CHU Pontchaillou, Rennes, France
¹⁹LYSARC, LYON, France
²⁰Nuclear medicine department, Henri Mondor University Hospital, AP-HP, Créteil, FRA
²¹Centre Eugene Marquis, Rennes, France
²²CHU Henri Mondor, Creteil, FRA
²³Scintidoc Nuclear Medicine Center, Montpellier, France
²⁴CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France
²⁵Pathology Department, Institut Universitaire du Cancer , Oncopole, Toulouse, France
²⁶Department of Hematology, Henri Mondor Hospital, CRETEIL, France
²⁷Rennes university hospital - Hospital Pontchaillou, Rennes, France

Anath Lionel, MD, PhD¹, Sushanth Gouni, MD², Lei Feng, MS^3*, Charles Gaulin, MBBS², Amrit S. Gonugunta, MD^4*, Turcin Saridogan^4*, Michelly Abreu^2*, Jaimole Varghese^2*, Karla Ow^2*, Minifrida Santiago^2*, Ajlan Al Zaki, MD, PhD⁵, Sherry Adkins, ANP^2*, Amy A. Ayers, MPH^2*, Misha Hawkins, MSN, RN^2*, Partow Kebriaei, MD⁶, Elizabeth J. Shpall, MD⁶, Swaminathan P Iyer, MD^2*, Preetesh Jain, MD, MBBS, PhD, DM², Michael Wang, MD², Christopher R. Flowers, MD, MS², Jeremy Ramdial, MD⁶, Loretta Nastoupil^2*, Jason R. Westin, MD², Paolo Strati, MD², Sattva S. Neelapu, MD², Deyali Chatterjee^7* and Sairah Ahmed, MD²

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Oakville, ON, Canada
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX
⁵Department of Lymphoma/Myeloma and Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Jacob Butman, MD^1*, Alma Habib, MD², Rina Li Welkie, MPH³, Yazeed Sawalha, MD², Audrey M. Sigmund, MD², Beth Christian, MD², Kami J. Maddocks, MD⁴, Walter Hanel, MD, PhD⁴, David A. Bond, MD, BS², Lapo Alinari, MD, Ph.D⁴, Robert Baiocchi, MD, PhD⁴, Hannah Choe, MD⁵, John C. Reneau, MD, PhD⁴, Gabriela Sanchez-Petitto, MD⁴, Jonathan E. Brammer⁴, Evandro Bezerra, MD², Timothy Voorhees, MD, MSc², Sumithira Vasu, MD, MBBS⁴, Sarah A. Wall, MD, MPH², Marcos de Lima, MD⁴ and Nathan Denlinger, DO, MS²

¹Department of Internal Medicine, The Ohio State University, Columbus, OH
²Division of Hematology, The Ohio State University, Columbus, OH
³The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH
⁴Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
⁵Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital, Columbus, OH

Sushanth Gouni, MD¹, Anath Lionel, MD, PhD², Lei Feng, MS^3*, Charles Gaulin, MBBS¹, Tejaswini Reddy, MD, PhD^4*, Amrit S. Gonugunta, MD^5*, Victoria Chu, MD, MBA^5*, Taylor Hopper, MD^5*, Amy A. Ayers, MPH^1*, Inimfon Jackson, MD, PhD, MPH⁶, Ajlan Al Zaki, MD, PhD⁷, Michelle A.T. Hildebrandt, PhD⁸, Loretta Nastoupil^1*, Dai Chihara, MD, PhD¹, Chijioke Nze, MD, MPH¹, Jeremy Ramdial, MD⁹, Elizabeth J. Shpall, MD⁹, Jason R. Westin, MD¹⁰, Christopher R. Flowers, MD, MS¹, Paolo Strati, MD¹, Sattva S. Neelapu, MD¹, Rachel Lynn, M.D^11* and Sairah Ahmed, MD¹

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Oakville, ON, Canada
³Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Internal Medicine, Baylor College of Medicine, Houston
⁵Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX
⁶The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma/Myeloma and Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰The University of Texas M D Anderson Cancer Center, Houston, TX
¹¹Department of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX

Efrat Luttwak, MD¹, Giulio Cassanello, MD^2*, Samantha Brown^3*, Sean M. Devlin, PhD^4*, Brandon S. Imber, MD, MA⁵, Andrew Ip, MD^6*, Lori A. Leslie, MD⁷, Noa Golan Accav^8*, Ofrat Beyar-Katz, MD, PhD^9*, Magdalena Corona, MD, PhD^10*, Alejandro Luna De Abia^11*, Alfredo Rivas-Delgado, MD, PhD¹, Jennifer Kimberly Lue, MD¹, Christian Grommes, MD^12*, Gunjan L. Shah, MD¹³, Jae H. Park, MD¹⁴, Miguel Angel Perales, MD¹⁵, Gilles Salles, MD, PhD¹⁶, Roni Shouval, MD, PhD¹⁷, Maria Lia Palomba, MD¹ and Michael Scordo, MD¹⁸

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Statistics, Memorial Sloan Kettering cancer center, New York
⁴Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Hackensack Meridian School of Medicine, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
⁷Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
⁸Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel
⁹Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus; The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel
¹⁰Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY
¹¹Memorial sloan Kettering Cancer center, NYC, NY
¹²Department of Neurology, Memorial Sloan Kettering Cancer, New York, NY
¹³Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Cell Therapy Service and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁵Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center,, New York
¹⁶Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁷Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁸Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY

Manali K. Kamdar, MD¹, Bradley M. Haverkos, MD, MS, MPH², Alexander W. Rankin, MD^3,4*, Cheri Adams, MSHS, RN^5*, Michael R Verneris, MD⁶, Andrew Roth, PhD^7*, Kimberly Jordan, PhD^7*, Navin R. Pinto, MD^8*, M. Eric Kohler, MD, Ph.D^9,10, Angela Ohm, MPH^7* and Terry J Fry, MD^11,12

¹University of Colorado, Denver, CO
²Division of Hematology, University of Colorado, Aurora, CO
³Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO
⁴Dept. of Pediatric Hematology/Oncology & BMT, Nationwide Children's Hospital, Columbus, OH
⁵Gates Institute, University of Colorado Anschutz Medical Campus, Aurora, CO
⁶University of Colorado, Anschutz Medical Campus, Colorado Children’s Hospital, Aurora, CO
⁷University of Colorado Anschutz Medical Campus, Aurora, CO
⁸Dept. of Pediatrics, Medical Oncology and Hematology, CU Anschutz School of Medicine, Aurora, CO
⁹Department of Pediatrics-Hematology, Oncology, and BMT, University of Colorado Anschutz Medical Campus, Aurora, CO
¹⁰Division of Hematology/Oncology/Bone Marrow Transplant and Center for Cancer and Blood Disorders, Ch, Aurora, CO
¹¹Department of Pediatrics- Hematology, Oncology, and Bone Marrow Transplant, University of Colorado Anschutz Medical Campus, Aurora, CO
¹²Immunology Department and HI3 Initiative, University of Colorado Anschutz Medical Campus, Aurora, CO

Hamish W Scott, MD^1,2*, Mark R Dowling, MBBS, PhD^2,3,4, Daniel Garcia^1*, Samantha van der Linde^1,2*, Nicole O'Leary^1,2*, Brydon Panozzo^1*, Adrian Minson, MBBS^1,5, James A Kuzich, MBBS, FRACP, FRCPA^1,5, Aaron Jun Ning Wong^5,6*, Michael S Hofman, MBBS^6,7*, Monique Youl^8*, Belinda Campbell^9*, Michael Patrick Macmanus, MD, MRCP, MBBS^8*, Philip A. Thompson, MBBS, FRACP, FRCPA^1,5, Mary Ann Anderson, MBBS, PhD, FRACP, FRCPA^1,5*, John F. Seymour, MBBS, PhD^1,5, Michael J Dickinson, MBBS, DMedSci, FRACP, FRCPA^1,10 and Simon J Harrison, MBBS, PhD^1,2,4

¹Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
²Centre of Excellence for Cellular Immunotherapy, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
³Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Coburg, Australia
⁴Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia
⁵Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia
⁶Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
⁷Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia
⁸Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
⁹Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
¹⁰Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia

Kunhwa Kim, MD¹, Dai Chihara, MD, PhD², Luis E. Fayad, MD³, Sattva S. Neelapu, MD², Sairah Ahmed, MD², Frederick Hagemeister^4*, Chijioke Nze, MD, MPH², Swaminathan P Iyer, MD^2*, Preetesh Jain, MD, MBBS, PhD, DM², Michael Wang, MD², Paolo Strati, MD², Fateeha Furqan, MBBS², Ayushi Chauhan, MD², Michael R. Green, PhD⁴, Christopher R. Flowers, MD, MS² and Jason R. Westin, MD⁵

¹Division of Cancer Medicine, The University of Texas MD Anderson, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
⁵The University of Texas M D Anderson Cancer Center, Houston, TX